Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
DentsplyXRAY |
$13M |
 |
Align TechnologyALGN |
-$137M |
 |
NovoCureNVCR |
-$124M |
 |
iRhythm TechnologiesIRTC |
-$608M |
 |
LeMaitre VascularLMAT |
-$3.96B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Landry Benjamin | Dec 5, 2025 | Sell | 27,425 | $2.6373 | $72,000 |
| Larson-Green Julie | Dec 4, 2025 | Sell | 47,997 | $2.6741 | $130,000 |
| Landry Benjamin | Sep 5, 2025 | Sell | 6,175 | $3.353 | $21,000 |
| Landry Benjamin | Jun 5, 2025 | Sell | 6,057 | $3.9443 | $24,000 |
| LeSueur Daniel | May 5, 2025 | Sell | 5,209 | $4.0951 | $21,000 |
| LeSueur Daniel | Apr 3, 2025 | Sell | 5,209 | $4.1475 | $22,000 |
| Landry Benjamin | Mar 6, 2025 | Sell | 13,827 | $4.5462 | $63,000 |
| LeSueur Daniel | Mar 5, 2025 | Sell | 16,902 | $4.5161 | $76,000 |
| Llewelyn Linda | Feb 18, 2025 | Sell | 6,441 | $5.4266 | $35,000 |
| LeSueur Daniel | Feb 5, 2025 | Sell | 5,209 | $5.7607 | $30,000 |
| Llewelyn Linda | Jan 15, 2025 | Sell | 6,442 | $5.7976 | $37,000 |
| LeSueur Daniel | Jan 6, 2025 | Sell | 5,209 | $7.5128 | $39,000 |
| Landry Benjamin | Jan 6, 2025 | Sell | 2,500 | $7.5182 | $19,000 |
| Gallagher Duncan | Dec 30, 2024 | Sell | 4,500 | $6.9298 | $31,000 |
| Gallagher Duncan | Dec 23, 2024 | Sell | 4,500 | $6.9812 | $31,000 |
| Llewelyn Linda | Dec 16, 2024 | Sell | 6,442 | $7.8848 | $51,000 |
| Alger Jason | Dec 6, 2024 | Sell | 19,599 | $8.3193 | $160,000 |
| Landry Benjamin | Dec 6, 2024 | Sell | 19,268 | $8.3192 | $160,000 |
| LeSueur Daniel | Dec 4, 2024 | Sell | 22,773 | $7.6952 | $180,000 |
| Freeman Kevin Lee | Dec 2, 2024 | Sell | 7,500 | $8.9431 | $67,000 |
| Llewelyn Linda | Nov 15, 2024 | Sell | 1,365 | $8.5 | $12,000 |
| LeSueur Daniel | Nov 5, 2024 | Sell | 5,209 | $7.7034 | $40,000 |
| Llewelyn Linda | Oct 15, 2024 | Sell | 1,324 | $8.16 | $11,000 |
| LeSueur Daniel | Oct 3, 2024 | Sell | 5,209 | $7.6812 | $40,000 |
| Llewelyn Linda | Sep 16, 2024 | Sell | 1,324 | $8.43 | $11,000 |
| Landry Benjamin | Sep 6, 2024 | Sell | 2,466 | $7.3891 | $18,000 |
| Alger Jason | Sep 6, 2024 | Sell | 2,899 | $7.3911 | $21,000 |
| LeSueur Daniel | Sep 4, 2024 | Sell | 8,137 | $7.5849 | $62,000 |
| Freeman Kevin Lee | Sep 3, 2024 | Sell | 7,500 | $7.2232 | $54,000 |
| Llewelyn Linda | Aug 15, 2024 | Sell | 1,328 | $6.57 | $8,700 |
| LeSueur Daniel | Aug 5, 2024 | Sell | 5,209 | $6.1863 | $32,000 |
| Llewelyn Linda | Jul 15, 2024 | Sell | 1,290 | $6.51 | $8,400 |
| LeSueur Daniel | Jul 3, 2024 | Sell | 5,208 | $6.1538 | $32,000 |
| Llewelyn Linda | Jun 17, 2024 | Sell | 1,290 | $6.3725 | $8,200 |
| Alger Jason | Jun 12, 2024 | Sell | 2,823 | $6.83 | $19,000 |
| Freeman Kevin Lee | Jun 11, 2024 | Sell | 7,500 | $6.5344 | $49,000 |
| Landry Benjamin | Jun 6, 2024 | Sell | 2,387 | $6.7105 | $16,000 |
| LeSueur Daniel | Jun 6, 2024 | Sell | 11,923 | $6.7151 | $80,000 |
| Landry Benjamin | May 31, 2024 | Sell | 12,577 | $6.6099 | $83,000 |
| Llewelyn Linda | May 15, 2024 | Sell | 2,066 | $7 | $14,000 |
| Llewelyn Linda | Apr 15, 2024 | Sell | 2,005 | $6.11 | $12,000 |
| Llewelyn Linda | Mar 15, 2024 | Sell | 2,005 | $7.8043 | $16,000 |
| Burton Daniel D. | Feb 27, 2024 | Buy | 26,200 | $7.8063 | $200,000 |
| Llewelyn Linda | Feb 15, 2024 | Sell | 3,262 | $9.7654 | $32,000 |
FAQ - Insider Transactions
The most recent insider transaction for Health Catalyst was conducted by Landry Benjamin, who sold 27,425 shares on December 5, 2025 at a price of $2.64 per share.
Burton Daniel D. has bought the most HCAT stock in the last 2 years, with a total value of $200,000.
LeSueur Daniel has sold the most HCAT stock in the last 2 years, with a total value of $650,000.
The total value of insider transactions for Health Catalyst in the last 2 years is negative, amounting to -$1.7M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Health Catalyst have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
